9-136676697-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006412.4(AGPAT2):c.493-17C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000484 in 1,610,610 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0026 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 1 hom. )
Consequence
AGPAT2
NM_006412.4 intron
NM_006412.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.228
Genes affected
AGPAT2 (HGNC:325): (1-acylglycerol-3-phosphate O-acyltransferase 2) This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 9-136676697-G-T is Benign according to our data. Variant chr9-136676697-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 259978.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0026 (396/152282) while in subpopulation AFR AF= 0.00912 (379/41578). AF 95% confidence interval is 0.00836. There are 2 homozygotes in gnomad4. There are 182 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGPAT2 | NM_006412.4 | c.493-17C>A | intron_variant | ENST00000371696.7 | NP_006403.2 | |||
AGPAT2 | NM_001012727.2 | c.492+264C>A | intron_variant | NP_001012745.1 | ||||
AGPAT2 | XM_047422636.1 | c.184-17C>A | intron_variant | XP_047278592.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGPAT2 | ENST00000371696.7 | c.493-17C>A | intron_variant | 1 | NM_006412.4 | ENSP00000360761.2 | ||||
AGPAT2 | ENST00000371694.7 | c.492+264C>A | intron_variant | 1 | ENSP00000360759.3 | |||||
AGPAT2 | ENST00000472820.1 | n.421-17C>A | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00260 AC: 395AN: 152166Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
395
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000671 AC: 168AN: 250188Hom.: 0 AF XY: 0.000487 AC XY: 66AN XY: 135650
GnomAD3 exomes
AF:
AC:
168
AN:
250188
Hom.:
AF XY:
AC XY:
66
AN XY:
135650
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000263 AC: 383AN: 1458328Hom.: 1 Cov.: 31 AF XY: 0.000243 AC XY: 176AN XY: 725706
GnomAD4 exome
AF:
AC:
383
AN:
1458328
Hom.:
Cov.:
31
AF XY:
AC XY:
176
AN XY:
725706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00260 AC: 396AN: 152282Hom.: 2 Cov.: 33 AF XY: 0.00244 AC XY: 182AN XY: 74456
GnomAD4 genome
AF:
AC:
396
AN:
152282
Hom.:
Cov.:
33
AF XY:
AC XY:
182
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2023 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Congenital generalized lipodystrophy type 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 23, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at